Making CAR-T Cell Therapy and Clinical Trials More Accessible

In laboratories around the country and the world, Australian researchers and clinicians are striving to find new blood cancer treatments to make it a curable disease for all. We are proud to support one such researcher, Queensland’s clinician scientist, Dr Siok Tey, who is recognised nationally and internationally for her work in bone marrow transplantation … Continued

International Collaboration to Fund Innovative Research into CAR T-cell Therapy and Paediatric Leukaemia

Snowdome is very proud to continue our collaboration with the prestigious Leukemia & Lymphoma Society USA and Australia’s Leukaemia Foundation to fund Australian researchers and clinicians specialising in blood cancer research. Now entering our fourth year of funding, we are delighted to announce funding for two more ground-breaking projects into treating paediatric leukaemia and CAR … Continued

Six marathons in four days, in honour of a mother lost to blood cancer

Alastair Evans set out to honour his mother, Sally, aiming to raise $75,000 for blood cancer research, through a fundraising event called The Positive Journey – a four-day 270km run from Melbourne to Echuca, his hometown. Joining with friends, family and donors, Alastair raised over $150,000, running the equivalent of six marathons. The funds raised … Continued

Snowdome ranked in the top 500 high growth companies in Asia-Pacific

We are very proud to announce that the Snowdome Foundation has earned a place in the High-Growth Companies Asia-Pacific 2021 ranking. The ranking assesses millions of companies from 13 countries and Snowdome made it into the top 500 fastest-growing companies in the region. Only 71 companies from Australia made into the top 500 and we … Continued

FDA approves the first CAR T-cell therapy for Multiple Myeloma

Multiple myeloma has been a notoriously difficult blood cancer to manage.  Relapses are common despite the advances that have been made in treatments over the years.  Idecabtagene vicleucel (Ide-cel) a new chimeric antigen receptor (CAR) T-cell therapy, has just been approved by the FDA for relapsed refractory multiple myeloma.  This is the first CAR T-cell … Continued

Clinical trials bring hope

For many patients access to a clinical trial can literally save their life.  In speaking to The West Australian newspaper, Prof Chan Cheah told reporter Katie Hampson, when he trained in Melbourne and the U.S he had a range of trials he could put a patient on when they had exhausted all other options.  These options … Continued